Uncategorized

Epidemiologist Michael Osterholm has been called ‘Dr. Doom.’ Now he’s more motivated than ever to understand what the older generation is leaving to its grandchildren.

The U.K. has ordered 40 million vaccine doses from Pfizer and BioNTech — enough for up to a third of the population.

A lack of calcium, iron and vitamin B12 could mean the rise in popularity of veganism causes health problems.

U.K. PM Boris Johnson said that the one-month lockdown in England will be replaced by a new three-tier system in regions and towns. French President Emmanuel Macron is expected to announce similar easing measures for the Christmas season on Tuesday.

The director of National Institute of Allergy and Infectious Diseases spoke about political transitions and past mistakes.

Your guide to staying mentally and physically healthy, coping with pandemic fatigue and managing your vaccine expectations.

Stocks were higher early Wednesday, as a rally faced off against a continued rise in cases of COVID-19.

The blanket is modeled on the “Original Pan Pizza.”

Stocks are once again set to start the week on the front foot, despite COVID-19 cases continuing to rise.

Bitcoin bull Michael Novogratz says that the world’s No. 1 digital currency has much more room to run as it streaks toward a its first record high since 2017.

The three-test approach is aimed at confirming a passenger’s negative status for COVID-19 throughout the travel journey.

Unilever will also halve food waste by 2025, five years earlier than its previous commitment.

Emmanuel Macron is vexed by world governments’ unenthusiastic solidarity with France over terrorism.

Apple products worth £5 million ($6.6 million) have been stolen from a lorry in a dramatic highway robbery 75 miles north of London, police said on Tuesday.

Thomas H. Kee Jr., president and chief executive of Stock Traders Daily and portfolio manager at Equity Logic, returns to Need to Know to offer a fresh market call. He says investors are going to wake up to a harsh reality in 2021.

The Hungarian and Polish governments have withdrawn their approval for the launch of the European Union’s €750 billion COVID-19 recovery fund.

CureVac expects to announce partnerships with vaccine developers and manufacturers in coming weeks to ramp up capacity of its potential vaccine candidate.

European banks are under pressure to consolidate to cope with ultralow interest rates.